| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Alexander B Sigalov | |
| P2860 | cites work | Efficiency of signalling through cytokine receptors depends critically on receptor orientation | Q22003959 |
| Cutting edge: inflammatory responses can be triggered by TREM-1, a novel receptor expressed on neutrophils and monocytes | Q22254042 | ||
| An allosteric mechanism for activation of the kinase domain of epidermal growth factor receptor | Q24293598 | ||
| An antagonist peptide-EPO receptor complex suggests that receptor dimerization is not sufficient for activation | Q27765986 | ||
| Structural analysis of receptor tyrosine kinases | Q28198048 | ||
| Antigen-specific blockade of T cells in vivo using dimeric MHC peptide | Q74388152 | ||
| Will any dimer do? | Q77530257 | ||
| Inhibition of NKG2D receptor function by antibody therapy attenuates transfer-induced colitis in SCID mice | Q80094783 | ||
| Immune cell signaling: a novel mechanistic model reveals new therapeutic targets | Q80109976 | ||
| New developments in FcepsilonRI regulation, function and inhibition | Q80168002 | ||
| Interaction between HIV gp41 fusion peptide and T cell receptor: putting the puzzle pieces back together | Q80405974 | ||
| Novel mechanistic concept of platelet inhibition | Q81274534 | ||
| More on: glycoprotein VI oligomerization: a novel concept of platelet inhibition | Q81493277 | ||
| Blockade of NKG2D signaling prevents the development of murine CD4+ T cell-mediated colitis | Q81503412 | ||
| Multichain immune recognition receptor signaling from spatiotemporal organization to human disease. Preface | Q82881371 | ||
| Disabled receptor signaling and new primary immunodeficiency disorders | Q83283130 | ||
| T Cell Antigen Receptor Peptide-Lipid Membrane Interactions Using Surface Plasmon Resonance | Q57372251 | ||
| CD4+NKG2D+ T Cells in Crohn’s Disease Mediate Inflammatory and Cytotoxic Responses Through MICA Interactions | Q60609019 | ||
| T cell antigen receptor (TCR) transmembrane peptides colocalize with TCR, not lipid rafts, in surface membranes | Q61863665 | ||
| LETTERS TO THE EDITOR | Q61863669 | ||
| T-cell antigen receptor transmembrane peptides modulate T-cell function and T cell-mediated disease | Q61863690 | ||
| Replication of Human Herpesvirus-6 in Thymocytes Activated by Anti-CD3 Antibody | Q68248919 | ||
| Enhancement of human herpesvirus 6 replication in adult human lymphocytes by monoclonal antibody to CD3 | Q68461627 | ||
| Identification of the fusion peptide of primate immunodeficiency viruses | Q28646799 | ||
| Homooligomerization of the cytoplasmic domain of the T cell receptor zeta chain and of other proteins containing the immunoreceptor tyrosine-based activation motif | Q28910404 | ||
| Visual detection of specific, native interactions between soluble and microbead-tethered alpha-helices from membrane proteins | Q31029756 | ||
| Role of amphipathic helix of a herpesviral protein in membrane deformation and T cell receptor downregulation | Q33386000 | ||
| Novel mechanistic insights into viral modulation of immune receptor signaling | Q33489627 | ||
| Receptor signaling: when dimerization is not enough | Q33723925 | ||
| HIV-1 fusion peptide targets the TCR and inhibits antigen-specific T cell activation | Q33892217 | ||
| Signaling by the TNF receptor superfamily and T cell homeostasis | Q34078765 | ||
| T cell receptor mimic peptides and their potential application in T-cell-mediated disease | Q34123421 | ||
| The organizing principle in the formation of the T cell receptor-CD3 complex. | Q34167740 | ||
| CD3-specific antibodies: a portal to the treatment of autoimmunity | Q34654024 | ||
| The recombinant T cell receptor strategy: insights into structure and function of recombinant immunoreceptors on the way towards an optimal receptor design for cellular immunotherapy | Q34729634 | ||
| Antiplatelet therapy: in search of the 'magic bullet'. | Q35550212 | ||
| Synthetic peptides as models for intrinsic membrane proteins | Q35590020 | ||
| Platelets and anti-platelet therapy. | Q35635269 | ||
| Immunotherapy: 1999-2004. | Q35811871 | ||
| Transmembrane peptides as inhibitors of ErbB receptor signaling | Q35919443 | ||
| Multichain immune recognition receptor signaling: different players, same game? | Q35920512 | ||
| Multi-chain immune recognition receptors: spatial organization and signal transduction | Q35975103 | ||
| CD3 delta immunodeficiency | Q36004355 | ||
| Multichain immune recognition receptors: similarities in structure and signaling pathways | Q36066971 | ||
| Design and structure of peptide and peptidomimetic antagonists of protein-protein interaction. | Q36107353 | ||
| Disruption of protein-protein interactions: towards new targets for chemotherapy | Q36120011 | ||
| Immune receptors: targets for therapy of leukemia/lymphoma, autoimmune diseases and for the prevention of allograft rejection | Q36135244 | ||
| Soluble T cell receptors: novel immunotherapies. | Q36154070 | ||
| Novel treatments for food allergy | Q36196457 | ||
| Ligand-induced asymmetry in histidine sensor kinase complex regulates quorum sensing | Q36310730 | ||
| SPOTS: signaling protein oligomeric transduction structures are early mediators of death receptor-induced apoptosis at the plasma membrane | Q36322794 | ||
| Coexistence of multivalent and monovalent TCRs explains high sensitivity and wide range of response | Q36402779 | ||
| New approaches to allergen immunotherapy | Q36561259 | ||
| New reagents on the horizon for immune tolerance | Q36598897 | ||
| The TREM receptor family and signal integration | Q36655903 | ||
| Optimizing synthesis and expression of transmembrane peptides and proteins | Q36762759 | ||
| Three is better than one: pre-ligand receptor assembly in the regulation of TNF receptor signaling | Q36797904 | ||
| Scaffolds for blocking protein-protein interactions | Q36824992 | ||
| Identification, using synthetic peptides, of the minimum amino acid sequence from the retroviral transmembrane protein p15E required for inhibition of lymphoproliferation and its similarity to gp21 of human T-lymphotropic virus types I and II | Q36829685 | ||
| Inhibition of lymphoproliferation by a synthetic peptide with sequence identity to gp41 of human immunodeficiency virus type 1 | Q36829695 | ||
| Transmembrane interactions as immunotherapeutic targets: lessons from viral pathogenesis | Q36916289 | ||
| Inflammatory bowel disease: progress and current concepts of etiopathogenesis | Q36986001 | ||
| From T-cell activation signals to signaling control of anti-cancer immunity | Q36990608 | ||
| Platelet glycoprotein VI. | Q37344358 | ||
| Signaling chain homooligomerization (SCHOOL) model | Q37344378 | ||
| Therapeutic application of transmembrane T and natural killer cell receptor peptides | Q37344389 | ||
| SCHOOL model and new targeting strategies | Q37344397 | ||
| Viral pathogenesis, modulation of immune receptor signaling and treatment | Q37344402 | ||
| Protein intrinsic disorder and oligomericity in cell signaling | Q37696321 | ||
| Glycoprotein VI oligomerization in cell lines and platelets | Q38303616 | ||
| T-cell antigen receptor assembly and cell surface expression is not affected by treatment with T-cell antigen receptor-alpha chain transmembrane Peptide | Q40161856 | ||
| Immunoreceptor transmembrane peptides and their effect on natural killer (NK) cell cytotoxicity | Q40196593 | ||
| Discrepancy in CD3-transmembrane peptide activity between in vitro and in vivo T-cell inhibition | Q40232571 | ||
| Lipidation and glycosylation of a T cell antigen receptor (TCR) transmembrane hydrophobic peptide dramatically enhances in vitro and in vivo function | Q40266192 | ||
| Hydrophobic transmembrane-peptide lipid conjugations enhance membrane binding and functional activity in T-cells | Q40351596 | ||
| Inhibition by transmembrane peptides of chimeric insulin receptors | Q40379804 | ||
| The beta subunit of the type I Fcepsilon receptor is a target for peptides inhibiting IgE-mediated secretory response of mast cells | Q40395149 | ||
| Implication of a retrovirus-like glycoprotein peptide in the immunopathogenesis of Ebola and Marburg viruses. | Q40468233 | ||
| Dimerization of cell surface receptors in signal transduction | Q40579106 | ||
| Transmembrane T-cell receptor peptides inhibit B- and natural killer-cell function | Q40660132 | ||
| T-cell antigen receptor peptides inhibit signal transduction within the membrane bilayer | Q40683537 | ||
| Herpesviral protein targets a cellular WD repeat endosomal protein to downregulate T lymphocyte receptor expression | Q40708596 | ||
| Role of CD3gamma and CD3delta cytoplasmic domains in cytolytic T lymphocyte functions and TCR/CD3 down-modulation | Q41114472 | ||
| A peptide derived from a beta2-adrenergic receptor transmembrane domain inhibits both receptor dimerization and activation. | Q41186190 | ||
| Transmembrane helical interactions and the assembly of the T cell receptor complex | Q41727804 | ||
| Designing transmembrane alpha-helices that insert spontaneously | Q41729430 | ||
| Downregulation of the T-cell receptor complex and impairment of T-cell activation by human herpesvirus 6 u24 protein | Q41818927 | ||
| Binding of intrinsically disordered proteins is not necessarily accompanied by a structural transition to a folded form | Q42041492 | ||
| A transmembrane domain-derived peptide inhibits D1 dopamine receptor function without affecting receptor oligomerization | Q42059792 | ||
| Specific short transmembrane sequences can inhibit transformation by the mutant neu growth factor receptor in vitro and in vivo. | Q42806142 | ||
| A colorimetric enzyme-linked on-bead assay for identification of synthetic substrates of protein tyrosine kinases | Q44014008 | ||
| Transmembrane interactions in the activation of the Neu receptor tyrosine kinase | Q44075117 | ||
| Signal transduction. Autoinhibition control | Q44429540 | ||
| T-cell inactivation and immunosuppressive activity induced by HIV gp41 via novel interacting motif | Q44672332 | ||
| Inhibition of collagen-induced platelet reactivity by DGEA peptide | Q44739673 | ||
| Polar residue tagging of transmembrane peptides | Q44781100 | ||
| Detection of a fusion peptide sequence in the transmembrane protein of human immunodeficiency virus | Q45831208 | ||
| Therapeutic application of T cell receptor mimic peptides or cDNA in the treatment of T cell-mediated skin diseases | Q45868897 | ||
| Intervention of an inflammation amplifier, triggering receptor expressed on myeloid cells 1, for treatment of autoimmune arthritis. | Q45990897 | ||
| Switching signals on or off by receptor dimerization | Q46100759 | ||
| Toll-like receptors as molecular switches | Q48546511 | ||
| Bioinformatic discovery of novel bioactive peptides. | Q50701607 | ||
| Computational design of peptides that target transmembrane helices. | Q51035378 | ||
| OKT3 and IL-2 treatment for purging of the latent HIV-1 reservoir in vivo results in selective long-lasting CD4+ T cell depletion. | Q52019286 | ||
| D-enantiomer peptide of the TCRalpha transmembrane domain inhibits T-cell activation in vitro and in vivo. | Q53860578 | ||
| Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins. | Q55244775 | ||
| Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus | Q56956215 | ||
| P433 | issue | 2 | |
| P921 | main subject | transmembrane protein | Q424204 |
| P304 | page(s) | 255-267 | |
| P577 | publication date | 2010-04-24 | |
| P1433 | published in | Cell Adhesion and Migration | Q15817193 |
| P1476 | title | New therapeutic strategies targeting transmembrane signal transduction in the immune system | |
| P478 | volume | 4 |
| Q40751111 | Cells diversify transmembrane signaling through the controlled chaos of protein disorder |
| Q37957768 | Evolution of immunity: no development without risk |
| Q47109042 | Measuring the Conformational Distance of GPCR-related Proteins Using a Joint-based Descriptor |
| Q92265666 | Membrane receptor activation mechanisms and transmembrane peptide tools to elucidate them |
| Q42030573 | Rationally designed ligand-independent peptide inhibitors of TREM-1 ameliorate collagen-induced arthritis |
| Q37044451 | SARS Coronavirus Fusion Peptide-Derived Sequence Suppresses Collagen-Induced Arthritis in DBA/1J Mice |
| Q49834468 | Targeting Intramembrane Protein-Protein Interactions: Novel Therapeutic Strategy of Millions Years Old. |
| Q33351190 | The SCHOOL of nature: I. Transmembrane signaling |
| Q41768887 | The SCHOOL of nature: II. Protein order, disorder and oligomericity in transmembrane signaling |
| Q34619705 | The SCHOOL of nature: III. From mechanistic understanding to novel therapies |
| Q41776844 | The SCHOOL of nature: IV. Learning from viruses |
| Q41864976 | Unusual biophysics of immune signaling-related intrinsically disordered proteins |
Search more.